Lawrence Mayer

Shares of Celator Pharmaceuticals Inc (NASDAQ: CPXX) were highly volatile on Monday after the company detailed positive data for its lead product candidate, VYXEOS, during an industry conference. Shares of Celator opened for trading at $15.57 on Monday and quickly surged to a 52-week high of $...